Participate
Submit abstract
Abstracts are now invited on the following topics. They should be submitted using the online abstract submission system.
Abstract Submission Deadline: 30 April 2026
Conference Topics
Systems vaccinology and AI
Vaccines against STIs
Models for vaccine development and evaluation
Pediatric vaccines
Therapeutic cancer vaccines
Social and political impacts of vaccination and vaccine policy
Vaccines against respiratory pathogens
One health vaccines
Vaccine safety
Vaccines for older adults and strategies to tackle immunosenescence
Vaccine, adjuvant and delivery technologies
Vector borne diseases
European vaccine development
Veterinary Vaccines
You can submit as many abstracts to the conference for review as you would like. If, after the review by the committee, you have more than one paper accepted for the conference, you will need to register to attend and pay an additional paper fee for each additional paper (i.e., for the 2nd, 3rd, 4th papers – not the 1st). Please note this is for papers that you are the presenting author of, not papers that you are co-author of.
Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence. Allow at least 2 hours for your receipt to be returned to you.
Generative AI policy
We support the responsible use of generative AI Tools in the preparation of conference abstracts, posters, and presentations. Any use of such tools must be transparently disclosed, including the tool used and how it was applied. Authors remain fully responsible for the accuracy and integrity of their work.
Please see our full author policy, which also applies to conference submissions: https://www-elsevier-com.ucc.idm.oclc.org/about/policies-and-standards/generative-ai-policies-for-journals
For revisions or queries regarding papers already submitted
For revisions or queries regarding abstracts already submitted please contact the Conference Content Executive, (please do not email credit card information under any circumstances). If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please DO NOT RESUBMIT your abstract, as this may lead to duplication. Please email the Conference Content Executive (please do not email credit card information under any circumstances) with details of any revisions or queries. Please quote your reference number if you have one. A condition of submission is that if accepted one of the authors will present at the conference.
Award Winners
Schneerson Robbins Award
Nominations are now closed
Previous recipients of the award:
2025: Mario Feldman, Washington University, St. Louis, USA
2024: Galit Alter Moderna, USA
2023: Maria Elena Bottazzi, Baylor College of Medicine, USA
2022: Rino Rappuoli, GlaxoSmithKline Vaccines, Italy
2019: Kathryn M. Edwards, Director, Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine, USA
2018: Carol J. Baker, University of Texas Health Science Center, USA
2017: Rachel Schneerson, National Institutes of Health, USA
Jenner Award Winner
Rebecca Cox, University of Bergen, Norway
Previous recipients of the award:
2025: Kanta Subbarao, Université Laval, Canada
2024: Kathleen Neuzil, Fogarty International Center, NIH, USA
2023: Robin Shattock, Imperial College London, UK
2022: Myron Levin, University of Colorado, USA
2019: Rino Rappuoli, Chief Scientist & Head of External Research and Development, GlaxoSmithKline Vaccines, USA
2018: Stanley A. Plotkin, University of Pennsylvania & Vaxconsult, USA
2017: John B Robbins, National Institutes of Health, USA
Early Career Researcher Award Winner
Young Chan Kim, University of Oxford, UK
Previous recipients of the award:
2025: Marios Koutsakos, The Peter Doherty Institute for Infection and Immunity, Australia
2024: David Martinez, Yale University School of Medicine, USA
2022: Daniela Weiskopf, La Jolla Institute for Immunology, USA
Host Country Early Career Researcher Award Winner
Eduard Puente-Massaguer, Icahn School of Medicine at Mount Sinai, USA